Search Results - "Powell, C Bethan"

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions by Lancaster, Johnathan M, Powell, C. Bethan, Chen, Lee-may, Richardson, Debra L

“…Abstract Women with germline mutations in the cancer susceptibility genes, BRCA1 or BRCA2 , associated with Hereditary Breast & Ovarian Cancer syndrome, have…”
Get full text

Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer by Walker, Joan L., Powell, C. Bethan, Chen, Lee‐may, Carter, Jeanne, Bae Jump, Victoria L., Parker, Lynn P., Borowsky, Mark E., Gibb, Randall K.

“…Mortality from ovarian cancer may be dramatically reduced with the implementation of attainable prevention strategies. The new understanding of the cells of…”
Get full text

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper by Randall, Leslie M, Pothuri, Bhavana, Swisher, Elizabeth M, Diaz, John P, Buchanan, Adam, Witkop, Catherine T, Bethan Powell, C, Smith, Ellen Blair, Robson, Mark E, Boyd, Jeff, Coleman, Robert L, Lu, Karen

“…Highlights • The Society of Gynecologic Oncology convened a multidisciplinary Genetics Summit. • The benefits and challenges of genetic risk assessment were…”
Get full text

Impact of body mass index on ovarian cancer survival varies by stage by Bandera, Elisa V, Lee, Valerie S, Qin, Bo, Rodriguez-Rodriguez, Lorna, Powell, C Bethan, Kushi, Lawrence H

“…Background: Research on the effect of body mass index (BMI) on ovarian cancer survival is inconsistent, but previous studies did not consider the possible…”
Get full text

Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy by Powell, C Bethan, Kenley, Eric, Chen, Lee-May, Crawford, Beth, McLennan, Jane, Zaloudek, Charles, Komaromy, Miriam, Beattie, Mary, Ziegler, John

“…Women who carry deleterious mutations of BRCA1 or BRCA2 genes have up to a 54% lifetime risk of developing ovarian cancer. After childbearing, women at high…”
Get full text

Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer by Nañez, Andrea, Stram, Douglas A., Bethan Powell, C., Garcia, Christine

“…•Rate of breast cancer diagnosis after ovarian cancer in women with BRCA pathogenic mutations was 14.5%.•The majority of breast cancers, 87%, were diagnosed at…”
Get full text

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions by Lancaster, Johnathan M, Powell, C. Bethan, Kauff, Noah D, Cass, Ilana, Chen, Lee-May, Lu, Karen H, Mutch, David G, Berchuck, Andrew, Karlan, Beth Y, Herzog, Thomas J

“…Abstract Women with germline mutations in the cancer susceptibility genes, BRCA1 or BRCA2 , associated with Hereditary Breast/Ovarian Cancer syndrome, have up…”
Get full text

Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index by Bandera, Elisa V, Lee, Valerie S, Rodriguez-Rodriguez, Lorna, Powell, C Bethan, Kushi, Lawrence H

“…Optimal chemotherapy dosing in obese patients remains uncertain, with variation in practice. Dose reduction strategies are often used to avoid chemotoxicity,…”
Get more information

Classification of postoperative complications in robotic-assisted compared with laparoscopic hysterectomy for endometrial cancer by Barrie, Allison, MD, Freeman, Alexandra H., MD, Lyon, Liisa, MS, Garcia, Christine, MD, Conell, Carol, PhD, Abbott, Laura H., MD, Littell, Ramey D., MD, Powell, C. Bethan, MD

“…Abstract Study Objective To compare intraoperative and postoperative surgical complications and outcomes between robotic-assisted and laparoscopic surgical…”
Get full text

Clinical outcomes and prognostic markers in uterine leiomyosarcoma: a population-based cohort by Garcia, Christine, Kubat, Jenna S, Fulton, Regan S, Anthony, Adam T, Combs, Mary, Powell, C Bethan, Littell, Ramey D

“…The aim was to identify clinical parameters and immunohistochemical markers predictive of recurrence and overall survival (OS) in a community cohort of…”
Get more information

Surveillance of survivors: Follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers by Chapman, Jocelyn S, Powell, C. Bethan, McLennan, Jane, Crawford, Beth, Mak, Julie, Stewart, Nicola, Chen, Lee-may

“…Abstract Objectives To characterize the post-operative care of BRCA1 and BRCA2 mutation carriers who undergo risk-reducing salpingo-oophorectomy (RRSO)…”
Get full text

Does Surgical Teaching Take Time? Resident Participation in Minimally Invasive Hysterectomy for Endometrial Cancer by Freeman, Alexandra H., MD, Barrie, Allison, MD, Lyon, Liisa, MS, Conell, Carol, PhD, Garcia, Christine, MD, Littell, Ramey D., MD, Powell, C. Bethan, MD

“…Abstract Study Objective To determine the association between resident involvement and operative time for minimally invasive surgery (MIS) for endometrial…”
Get full text

Risk reducing salpingo-oophorectomy for BRCA mutation carriers: Twenty years later by Powell, C. Bethan

Get full text

Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival by Bandera, Elisa V, Lee, Valerie S, Rodriguez-Rodriguez, Lorna, Powell, C Bethan, Kushi, Lawrence H

“…Among patients with ovarian cancer, African American (AA) women experience poorer survival compared with other race/ethnicity groups. This has been attributed…”
Get full text

Salpingectomy for Sterilization: Change in Practice in a Large Integrated Health Care System, 2011–2016 by Powell, C. Bethan, Alabaster, Amy, Simmons, Sarah, Garcia, Christine, Martin, Maria, McBride-Allen, Sally, Littell, Ramey D.

“…OBJECTIVE:To evaluate the utilization rate of salpingectomy for cesarean deliveries and postpartum and interval tubal sterilization procedures. METHODS:This is…”
Get full text

Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system by Powell, C Bethan, Laurent, Cecile, Garcia, Christine, Hoodfar, Elizabeth, Karlea, Audrey, Kobelka, Christine, Lee, Jaimie, Roh, Janise, Kushi, Lawrence H

“…To describe breast and ovarian cancer risk reduction strategies in the clinical management of women who test positive for non-BRCA hereditary breast and…”
Get full text

Ovarian cancer surveillance in the clinical follow up of women with known BRCA1 or BRCA2 pathogenic variants in a large health care system by Nañez, Andrea, Stram, Douglas A., Garcia, Christine, Powell, C. Bethan

“…To assess CA 125 and transvaginal ultrasound surveillance in women with BRCA1 or BRCA2 pathogenic variants in a pragmatic clinical setting with>1 year follow…”
Get full text

Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations by Powell, C. Bethan, Alabaster, Amy, Armstrong, Mary Anne, Stoller, Nicole, Raine-Bennett, Tina

“…Estimate the prevalence of cardiovascular disease risk factors and endpoints in women with BRCA mutations. Women, age 40 and older, with BRCA mutations…”
Get full text

Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations by Salyer, Chelsea, Kobelka, Christine, Barrie, Allison, Weintraub, Miranda Ritterman, Powell, C. Bethan

“…Describe clinical characteristics and risk reducing strategies utilized among women with a BRCA mutation who lived to age 75 and above. A retrospective study…”
Get full text

In response to Peshkin et al. “Genetic counseling and testing for hereditary cancer risk in young adult women: Facilitating autonomy and informed decision making is key” by Powell, C. Bethan, MD, Richardson, Debra L., MD, Chen, Lee-may, MD

Get full text